We work closely with entrepreneurs and investors at the forefront of the global healthcare revolution. Our in-depth sector knowledge, combined with our technical capability, enables us to help corporates and investors capitalise on the enormous opportunities across the sector as they seek to consolidate and grow their market positions.
The ageing population, technological change, and increased demand for healthcare products and services, all create great opportunities in the health and social care, medical devices, life sciences, bioscience and pharmaceutical markets. Our job is to help our clients maximise those opportunities.
Adviser to Capsa Healthcare on the acquisition of RoboPharma B.V.
View moreDay Lewis Plc refinanced existing facilities with Lloyds Bank, NatWest, Santander and HSBC
View moreAdviser to Blue Equity and Chrispa on the sale of Controlled Polymers to Americhem
View moreAdviser to Blue Equity and Jesper Holm on the sale of Graphic West International to CCL Industries
View moreAdviser to Waterland Private Equity on raising debt finance from LGT Capital Partners to support the acquisition of imc group
View moreAdviser to BD on the acquisition of infusion assets from Pengyao Pharmaceutical
Adviser to Vivamus on its sale to Altiden, a subsidairy of Ambea
View moreAdviser to LDC on the MBO of Ashton Hospital Pharmacy Services supported by Silicon Valley Bank
View moreAdviser to the shareholders of 5 Santé on its sale to Korian
View moreAdviser to Palatine Private Equity on the sale of Vernacare Group to H.I.G. Capital
View moreAdvisers to the shareholders of Mathilde Médical Développement group on its sale to Vivalto Santé
View moreAdviser to the shareholders of Adonia Medical Group, on its sale to the sk:n Group
View moreLuc Bertholat, Partner, Naxicap PartnersClearwater has been very professional in leading the process involving candidates from all over the world.
The team were quickly able to identify the right partner for us and used their excellent relationship with the buyer to help negotiate a transaction that met our objectives.Dan Smart, CEO, Proclinical
With in-depth knowledge and technical capability, our healthcare team has a great track record of delivering tailored solutions.
See our teamOver 40
deals advised upon
in the last 5 years
€4.6bn
in deal value
over the last 5 years
45%
deals involving PE
in the last 5 years
The ongoing coronavirus pandemic has placed unprecedented levels of strain on global healthcare systems, with a lack of equipment — notably personal protective equipment and ventilators — and resources to cope with the sudden influx of critically ill patients.
Read more
The ongoing coronavirus pandemic has placed unprecedented levels of strain on global healthcare systems, with a lack of equipment — notably personal protective equipment and ventilators — and resources to cope with the sudden influx of critically ill patients.
Read more
LIDAR (Light Imaging Detection and Ranging) measures the distance to a target by illuminating it with a laser light and then measuring the reflected light with a sensor. This information can then be used to make digital 3D representations of the target.
Read more
